Explore This Research Lab

About the Morizane Lab

The Morizane Lab focuses on kidney disease studies using stem cell-derived tissues. Specifically, we are generating 3D kidney tissues termed organoids from human pluripotent stem cells (hPSCs). Kidney organoids consist of multiple cell types of kidneys, serving as a novel tool for drug development and regenerative medicine. Our group is divided into three main subgroups:

  • Stem cell differentiation: We are creating novel methods to differentiate hPSCs into matured kidney tissues. We employ automated cell culture, organ-on-a-chip, 3D imaging and multiomics to improve the induced kidney tissues
  • Kidney injury and repair: We are utilizing kidney organoids to understand intrinsic repair mechanisms of kidney epithelial cells. Our interests range from acute kidney injury to chronic kidney disease
  • Genome editing and genetic kidney diseases: We are generating genetic disease models using genome editing and iPS reprogramming. Our current focus includes autosomal polycystic kidney disease

Our Team

Ryuji Morizane, MD, PhD
Principal Investigator

Research Staff, Nephrology Division, Massachusetts General Hospital
Assistant Professor, Department of Medicine, Harvard Medical School
Affiliated Faculty, Harvard Stem Cell Institute
Visiting Scholar, Wyss Institute, Harvard University

Dr. Morizane is a physician-scientist at Massachusetts General Hospital and Harvard Medical School. He has a long-standing interest in translational research using hPSCs for kidney diseases and drug discovery. He has been working on pluripotent stem cell research since 2007 and established protocols to induce kidney lineage cells. His seminal work enabled the generation of nephron progenitor cells and kidney organoids from hPSCs with high efficiency, leading to his NIH Director’s New Innovator Award in 2019.

Navin Gupta
Instructor

Ken Hiratsuka
Postdoctoral fellow

Kazumi Ida
Research Technician

Kenichi Kobayashi
Postdoctoral fellow

Astia Safitri
Postdoctoral fellow

Eleanor Wu
High school student

Chengcheng Zhang
Reseach Technician

Research Opportunities

We accept fellows and visiting scientists from both academia and industry. Innovation Fellows Program enables personnel exchanges between our lab and participating industry. Should you have any questions, please contact Dr. Morizane.

Ryuji Morizane, MD, PhD
Email: rmorizane@mgh.harvard.edu

Publications

2022

Traitteur Tamara, Chengcheng Zhang, and Ryuji Morizane. 1/9/2022. “iPSCs - State of the Science.” In Elsevier. Publisher's Version

Navin Gupta, Takuya Matsumoto, Ken Hiratsuka, Edgar Garcia Saiz, Pierre Galichon, Tomoya Miyoshi, Koichiro Susa, Narihito Tatsumoto, Michifumi Yamashita, and Ryuji Morizane. 2022. “Modeling injury and repair in kidney organoids reveals that homologous recombination governs tubular intrinsic repair.” Sci Transl Med, 14, 634, Pp. eabj4772. Publisher's Version Abstract

2021

Astia Rizki-Safitri, Tamara Traitteur, and Ryuji Morizane. 2021. “Bioengineered Kidney Models: Methods and Functional Assessments.” Function, 2, 4. Publisher's Version Abstract

Navin Gupta and Ryuji Morizane. 2021. “Kidney development to kidney organoids and back again.” Semin Cell Dev Biol. Abstract

Krishanu Saha, Erik J Sontheimer, PJ Brooks, Melinda R Dwinell, Charles A Gersbach, David R Liu, Stephen A Murray, Shengdar Q Tsai, Ross C Wilson, Daniel G Anderson, Aravind Asokan, Jillian F Banfield, Krystof S Bankiewicz, Gang Bao, Jeff WM Bulte, Nenad Bursac, Jarryd M Campbell, Daniel F Carlson, Elliot L Chaikof, Zheng-Yi Chen, Holland R Cheng, Karl J Clark, David T Curiel, James E Dahlman, Benjamin E Deverman, Mary E Dickinson, Jennifer A Doudna, Stephen C Ekker, Marina E Emborg, Guoping Feng, Benjamin S Freedman, David M Gamm, Guangping Gao, Ionita C Ghiran, Peter M Glazer, Shaoqin Gong, Jason D Heaney, Jon D Hennebold, John T Hinson, Anastasia Khvorova, Samira Kiani, William R Lagor, Kit S Lam, Kam W Leong, Jon E Levine, Jennifer A Lewis, Cathleen M Lutz, Danith H Ly, Samantha Maragh, Paul B McCray, Todd C McDevitt, Oleg Mirochnitchenko, Ryuji Morizane, Niren Murthy, Randall S Prather, John A Ronald, Subhojit Roy, Sushmita Roy, Venkata Sabbisetti, Mark W Saltzman, Philip J Santangelo, David J Segal, Mary Shimoyama, Melissa C Skala, Alice F Tarantal, John C Tilton, George A Truskey, Moriel Vandsburger, Jonathan K Watts, Kevin D Wells, Scot A Wolfe, Qiaobing Xu, Wen Xue, Guohua Yi, and Jiangbing Zhou. 2021. “The NIH Somatic Cell Genome Editing program.” Nature, 592, 7853, Pp. 195-204. Abstract

2020

Navin Gupta, Emre Dilmen, and Ryuji Morizane. 10/9/2020. “3D kidney organoids for bench-to-bedside translation.” Journal of Molecular Medicine. Abstract

Sandrine Ettou, Youngsook L. Jung, Tomoya Miyoshi, Dhawal Jain, Ken Hiratsuka, Valerie Schumacher, Mary E. Taglienti, Ryuji Morizane, Peter J. Park, and Jordan A. Kreidberg. 7/24/2020. “Epigenetic transcriptional reprogramming by WT1 mediates a repair response during podocyte injury.” Science Advances, 6, 30, Pp. eabb5460. Publisher's Version Abstract

2019

Seiji Kishi, Craig R Brooks, Kensei Taguchi, Takaharu Ichimura, Yutaro Mori, Akinwande Akinfolarin, Navin Gupta, Pierre Galichon, Bertha C Elias, Tomohisa Suzuki, Qian Wang, Leslie Gewin, Ryuji Morizane, and Joseph V Bonventre. 11/1/2019. “Proximal tubule ATR regulates DNA repair to prevent maladaptive renal injury responses.” The Journal of Clinical Investigation, 11, 129, Pp. 4797-4816. Publisher's Version Abstract

Takuya Matsumoto, Olivier J.M. Schäffers, Wenqing Yin, and Ryuji Morizane. 7/30/2019. “Renal Regeneration: Stem Cell-Based Therapies to Battle Kidney Disease.” EMJ Nephrol., 7, 1, Pp. 54-64. Publisher's Version Abstract

Miyoshi T, Hiratsuka K, Garcia Saiz E, and Morizane R. 3/6/2019. “Kidney Organoids in Translational Medicine: Disease Modeling and Regenerative Medicine.” Developmental Dynamics. Publisher's Version Abstract

Morizane R. 2/18/2019. “Modelling diabetic vasculopathy with human vessel organoids.” Nature Reviews Nephrology. Publisher's Version Abstract

Kimberly A. Homan, Navin Gupta, Katharina T. Kroll, David B. Kolesky, Mark Skylar-Scott, Tomoya Miyoshi, Donald Mau, M. Todd Valerius, Thomas Ferrante, Joseph V. Bonventre, Jennifer A. Lewis, and Ryuji Morizane. 2/11/2019. “Flow-enhanced vascularization and maturation of kidney organoids in vitro .” Nature Methods. Publisher's Version Abstract

Morizane R. 1/31/2019. “Revealing potential cardiac manifestation of ADPKD using iPS cell-derived cardiomyocytes.” EBioMedicine. Publisher's Version

Hiratsuka K, Monkawa T, Akiyama T, Nakatake Y, Oda M, Goparaju SK, Kimura H, Chikazawa-Nohtomi N, Sato S, Ishiguro K, Yamaguchi S, Suzuki S, Morizane R, Ko SBH, Itoh H, and Ko MSH. 1/29/2019. “Induction of human pluripotent stem cells into kidney tissues by synthetic mRNAs encoding transcription factors.” Scientific Reports, 9, 1, Pp. 913. Abstract

2018

Hill SJ, Decker B, Roberts EA, Horowitz NS, Muto MG, Worley MJ Jr, Feltmate CM, Nucci MR, Swisher EM, Nguyen H, Yang C, Morizane R, Kochupurakkal BS, Do KT, Konstantinopoulos PA, Liu JF, Bonventre JV, Matulonis UA, Shapiro GI, Berkowitz RS, Crum CP, and D'Andrea AD. 11/2018. “Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids.” Cancer Discov., 8, 11, Pp. 1404-1421. Abstract

Dario R Lemos, Michael McMurdo, Gamze Karaca, Julia Wilflingseder, Irina A Leaf, Navin Gupta, Tomoya Miyoshi, Koichiro Susa, Bryce G Johnson, Kirolous Soliman, Guanghai Wang, Ryuji Morizane, Joseph V Bonventre, and Jeremy S Duffield. 5/8/2018. “Interleukin-1β Activates a MYC-Dependent Metabolic Switch in Kidney Stromal Cells Necessary for Progressive Tubulointerstitial Fibrosis.” Journal of the American Society of Nephrology. Abstract

Navin Gupta, Koichiro Susa, Yoko Yoda, Joseph V. Bonventre, M. Todd Valerius, and Ryuji Morizane. 2018. “CRISPR/Cas9‐based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.” Current Protocols in Stem Cell Biology. Abstract

Ryuji Morizane and Joseph Bonventre. 2018. “Organoids for modeling kidney disease.” In Organs and Organoids, Pp. 227-245. Elsevier Inc. Abstract